Also trades as: CHG.BK (SET) · $vol 2M
CHG-R.BK SET
Chularat Hospital Public Company Limited
1W: -3.8%
1M: -2.6%
3M: -5.0%
YTD: -7.9%
1Y: -16.0%
3Y: -44.1%
฿1.52 ($0.05)
-0.01 (-0.65%)
Weekly Expected Move ±3.1%
฿1
฿1
฿2
฿2
฿2
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$1.7B
-3.4% ▼
5Y CAGR: +5.0%
Capital Expenditures
$683M
-16.8% ▼
5Y CAGR: +18.4%
Free Cash Flow
$971M
-13.9% ▼
5Y CAGR: -0.7%
Dividends Paid
$770M
-0.0% ▼
Buybacks
$0
+0.0% ▲
Net Change in Cash
$76M
-73.8% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $5.3B | $3.6B | $1.0B | $978M | $929M |
| Depreciation & Amort. | $351M | $382M | $441M | $497M | $506M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$1.3B | -$63M | $597M | $231M | $158M |
| Other Non-Cash Items | -$356M | -$1.2B | $4M | -$261M | $61M |
| Operating Cash Flow | $4.0B | $2.6B | $2.1B | $1.7B | $1.7B |
| — Investing Activities — | |||||
| Capital Expenditures | -$484M | -$823M | -$1.1B | -$563M | -$683M |
| Acquisitions (Net) | $42M | -$143M | -$138M | $0 | $4M |
| Investment Purchases | -$113 | -$143M | -$125M | $0 | $0 |
| Investment Sales | $32M | $143M | $350K | $0 | $0 |
| Other Investing | -$38M | $8M | -$52M | $13M | $0 |
| Investing Cash Flow | -$447M | -$958M | -$1.4B | -$550M | -$679M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$672M | $347M | -$246M | -$60M | -$95M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | -$660M | -$2.8B | -$1.0B | -$770M | -$770M |
| Other Financing | $16M | -$2M | $44M | -$41M | -$34M |
| Financing Cash Flow | -$1.3B | -$2.5B | -$1.2B | -$871M | -$898M |
| Net Change in Cash | $2.2B | -$789M | -$601M | $292M | $76M |
| Cash End of Period | $2.8B | $2.0B | $1.4B | $1.7B | $1.8B |
| Free Cash Flow | $3.5B | $1.8B | $952M | $1.1B | $971M |